Call for tenders: Next Generation Sequencing for Oncology

Increasing the use of Next Generation Sequencing (NGS) in oncology requires further cost reduction and technology acceleration. 8 health procurers from 5 countries (BE, FR, DE, ES, IT) invite potentially interested bidders to submit an offer for their oncNGS pre-commercial procurement.

Aim of the procurement is to develop an affordable integrated solution for predictive, prognostic and diagnostic analysis in liquid biopsies of solid tumours based on NGS technology. Deadline for submission of offers: extended to 17 October 2022.

Tags:

ads
  • Show Comments

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

You May Also Like

Vote in the Innovation Radar Prize 2019 to shine a light on Europe’s world-class innovators

The European Commission has launched a competition to identify Europe’s top future innovators. The ...

StartupsVsCovid19: Call for innovative solutions to combat COVID-19

Targeting young innovative enterprises, the call for projects focuses on the development of technology-based ...

X
/